All In MedTech

Device Trial Radar · NCT05634408

Evaluating ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management

Last checked: Nov 20, 2026Latest source record: Jan 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

75

Actual

Start

Dec 24, 2022

Primary completion

Aug 20, 2025

Study completion Aug 20, 2025

Sponsor

Lead sponsor
Johnson & Johnson Vision Care, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 2, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 7 years, up to 12 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a single-site, prospective, single-arm, open-label, real-world evidence study with a minimal study duration of 1-year, up to 2-year follow-up to evaluate overall visual acuity.

Conditions

  • Visual Acuity

Interventions

  • ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management (A1D)Device

    TEST Lens

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Axial Length (AL) from baselineTime frame: Up to 24-month follow-up
  2. Change in Spherical Equivalent of Cycloplegic Autorefraction (SECAR) from baselineTime frame: up to 24-month follow-up
  3. Serious and significant ocular adverse events (AEs)Time frame: up to 24-month follow-up

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hainan Boao Lecheng AIER Eye Hospital Co. LTD

    Qionghai, Hainan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.